abstract |
PROBLEM TO BE SOLVED: To provide a new drug leading to treatment of prostate cancer. The extracellular vesicle secretion inhibitor of the present invention is an extracellular vesicle secretion inhibitor that suppresses the secretion of extracellular vesicles from prostate cancer cells, and is SHC4, PFDN4, CHORDC1, NSD1, and SRM. It is characterized by containing an inhibitor that suppresses the expression or function of at least one protein selected from the group consisting of. In addition, the therapeutic agent for prostate cancer of the present invention is characterized by containing the extracellular vesicle secretion inhibitor of the present invention. [Selection diagram] Fig. 1 |